<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "https://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" dtd-version="1.2" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJMABHR</journal-id>
<journal-title-group><journal-title>International Journal of Medical and All Body Health Research</journal-title><abbrev-journal-title>IJMABHR</abbrev-journal-title></journal-title-group>
<issn pub-type="epub">2582-8940</issn>
<publisher><publisher-name>Anfo Publication House</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">178</article-id>
<title-group><article-title>The immunological evaluate of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) co-infection with plasmodium in Wukari, Taraba State, North East, Nigeria</article-title></title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><name><surname>Kenneth</surname><given-names>Imarenezor Edobor Peter</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author"><name><surname>Vivian</surname><given-names>Anyiam Ifeoma</given-names></name><xref ref-type="aff" rid="aff2"/></contrib>
<contrib contrib-type="author"><name><surname>Onolunosen</surname><given-names>Abhadionmhen Abel</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author"><name><surname>Husseni</surname><given-names>Iduku</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<aff id="aff1"><label>1</label>Tropical diseases Unit, Department of Microbiology, Federal University Wukari, Taraba State, Nigeria</aff>
<aff id="aff2"><label>2</label>Department of Microbiology, Federal University Otuoke, Bayelsa State, Nigeria</aff>
</contrib-group>
<pub-date publication-format="electronic" date-type="pub"><year>2023</year></pub-date>
<volume>4</volume>
<issue>2</issue>
<fpage>43</fpage>
<lpage>47</lpage>
<history>
<date date-type="received"><day>17</day><month>05</month><year>2023</year></date>
<date date-type="accepted"><day>07</day><month>06</month><year>2023</year></date>
</history>
<permissions><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-sa/4.0/?utm"><license-p>CC BY-NC-SA 4.0</license-p></license></permissions>
<self-uri xlink:href="https://www.allmedicaljournal.com/article/178/the-immunological-evaluate-of-hepatitis-b-virus-hbv-and-hepatitis-c-virus-hcv-co-infection-with"/>
<self-uri content-type="pdf" xlink:href="https://www.allmedicaljournal.com/article/178/download"/>
<abstract><p>Blood serves as a vehicle for transmission of blood-borne pathogens including hepatitis viruses and hemoparasities. In Taraba State, screening of blood for blood-borne pathogens does not fulfill the standard protocols and screening for malaria parasites is not practiced. This study was to determine the immunological evaluation of Hepatitis B Virus, Hepatitis C Virus and Plasmodium co-infection profile among individuals in Wukari. One hundred (100) venous blood samples was obtained from individuals age between 15 to 74 years randomly using a dry sterile syringe and needle; the blood is withdrawn from a suitable vein in the arm and the blood sample was slowly ejected into sample tube (EDTA container) and standard microbiological techniques were observed. The result denotes an overall prevalence of HBV, HCV and malaria parasites to be 15%, 6.0% and 2% respectively. It also shows in terms of sex and age groups that HBV has the highest prevalence within age group of 25-34, 4 (4.0%) for male and 25-34, 4 (4.0%) for female, while, HCV has the least prevalence within the age group of 15-24, 1 (10%) and 25-34, 1 (10%), for male and age group of 15-24, 1 (10%), 25-34, 1 (10%) and 35-44, 1 (10%) for females. The male population was the only one tested positive for malaria parasite from the age group of 15-24, 2 (2.0%). There was no co-infection of Hepatitis B virus, Hepatitis C and malaria, despite having prevalence of 15%, 6% and 2% respectively. The research on its own has shown that in order to reduce HBV, HCV and plasmodium co-infection, mass immunization of adults and antiviral drugs should be provided for those that are infected, while HBV, HCV and plasmodium co-infections screening programs should be instituted in all levels of institutions, communities and societies in the North East region, Taraba state in particular and the country in general to reduce the prevalence rate and level of transmission of hepatitis virus. This study also has added to the puddle of knowledge in this area of research.


 </p></abstract>
<kwd-group kwd-group-type="author"><kwd>Co-infection</kwd><kwd>Hepatitis B Virus</kwd><kwd>Hepatitis C Virus</kwd><kwd>Plasmodium</kwd><kwd>Wukari</kwd><kwd>North East</kwd></kwd-group>
</article-meta>
</front>
<back><ref-list><title>References</title>
<ref id="R1"><label>1</label><mixed-citation>Imarenezor EPK, Brown STC, Yakubu OE, Soken DC. Survey of Hepatitis B and C among students of Federal University Wukari, Taraba State, Nigeria. International Research Journal of Medicine and Medical Sciences. 2016; 4(3):31-37.</mixed-citation></ref>
<ref id="R2"><label>2</label><mixed-citation>Imarenezor Edobor Peter Kenneth. Incidence of Malaria Parasite in Pregnant and Non Pregnant Women in Ewohimi, Edo State, Nigeria. American Journal of Microbiology and Biotechnology. 2017; 4(6):97-99.</mixed-citation></ref>
<ref id="R3"><label>3</label><mixed-citation>Imarenezor Edobor Peter Kenneth, Onolunosen Abel Abhadionmhen, Sunday Danya, Joyce Briska, Paula Paul Shinggu. Sero-prevalence of Hepatitis B virus and plasmodium co-infection profile among patients in Wukari and Environs, North East Nigeria. International Journal of Science and Research Archive. 2021; 03(01):114-123.</mixed-citation></ref>
<ref id="R4"><label>4</label><mixed-citation>Friemanis GL, Owuso-Ofori S, Allain JP. Hepatitis B Virus Infection does not significantly influence Plasmodium parasite density in asymptomatic infections International Journal of Medical and All Body Health Research www.allmedicaljournal.com in Ghanian transfusion recipients. PLoS ONE. 2012; 7(11):e49967.</mixed-citation></ref>
<ref id="R5"><label>5</label><mixed-citation>Paulyn TA, Terdzungwe TS. Prevalence of plasmodia and HBV co-infection in blood donors at Bishop Murray Murray Medical Centre, Markurdi, Benue State, Nigeria: Asian Pacific Journal of Tropical Medicine, 2010, 22-26.</mixed-citation></ref>
<ref id="R6"><label>6</label><mixed-citation>World Health Organization [WHO]. World malaria report 2017. Geneva, 2017.</mixed-citation></ref>
<ref id="R7"><label>7</label><mixed-citation>World Health Organization [WHO]. Antimicrobial resistance: global report on surveillance, 2014.</mixed-citation></ref>
<ref id="R8"><label>8</label><mixed-citation>Jeya DB, Botelho de suza RA, Batista da Silva E. Co-human infection by Plasmodium and hepatitis B: Clinical aspect, Immunological and Serological: Tropical Medicine Foundation of Amazon,2010.</mixed-citation></ref>
<ref id="R9"><label>9</label><mixed-citation>World Health Organization [WHO]. World malaria report 2018. Geneva, 2018.</mixed-citation></ref>
<ref id="R10"><label>10</label><mixed-citation>Zhang Z, Zehnder B, Damrau C, Urban S. Visualization of Hepatitis B Virus entry - novel tools and approaches to directly follow virus entry into hepatocytes. FEBS Letters. 2016; 590(13):1915-1926.</mixed-citation></ref>
<ref id="R11"><label>11</label><mixed-citation>Cheesbrough M. District Laboratory Practice in Tropical Countries Part 1 (2nd Ed.). Cambridge University Press, Cambridge, UK., 2009, 239-258.</mixed-citation></ref>
<ref id="R12"><label>12</label><mixed-citation>Mboto C, Edet EJ. Prevalence rate of Hepatitis. International Journal Modern Biol Med. 2016; 2(2):101-111.</mixed-citation></ref>
<ref id="R13"><label>13</label><mixed-citation>Scotto G, Fazio V. Hepatitis B. Asymptomatic malaria coinfection in Sub-Saharan African immigrants: epidemiological and clinical features of HBV infection. Revista da Sociedade Brasileira de Medicina Tropical. 2018; 51(5):578-583.</mixed-citation></ref>
<ref id="R14"><label>14</label><mixed-citation>Bello RH, Olabode HOK. Human immunodeficiency virus (HIV) and hepatitis B virus (HBV) co-infection amongst patients in Biu, Borno state- Nigeria. International Research Journal of Microbiology. 2013; 2:507-509.</mixed-citation></ref>
<ref id="R15"><label>15</label><mixed-citation>Musa B, Bussell S, Borodo MM, Samaila AA, Femi OL. Prevalence of Hepatitis B Virus infection in Nigeria, 2000‑2013: A systematic review and meta‑analysis. Nigerian Journal of Clinical Practice. 2015; 18:163‑172.</mixed-citation></ref>
<ref id="R16"><label>16</label><mixed-citation>Udeze AO, Adeoye PA, Odugbes AE, Sule WF, Okonkwo IO. Hepatitis B and C seropositivity in a cohort of positive patients in Ilorin, north-central. Nigeria Journal of Microbiology. 2015; 28:2767-2776.</mixed-citation></ref>
<ref id="R17"><label>17</label><mixed-citation>Eyster ME, Alter HJ, Aledort LM, Quan S, Hatzakis A, Goedert JJ. Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Annals International Medicine. 2021; 115(10):764-8.</mixed-citation></ref>
<ref id="R18"><label>18</label><mixed-citation>World Health Organization [WHO]. Global policy report on the prevention and control of viral hepatitis, 2015.</mixed-citation></ref>
<ref id="R19"><label>19</label><mixed-citation>Ezeani MC, Oluchi O, Onyenekwe CC, Meludu SC, Okonkwo J, Ukibe NR. Prevalence of HBV and HCV amongst blood donors in Nigeria. Journal Biomed Investigat. 2016; 4(2):32-36.</mixed-citation></ref>
</ref-list></back>
</article>